Djebbari, F., Rampotas, A., Vallance, G., Panitsas, F., Basker, N., Sangha, G., Salhan, B., Karim, F., Firas, A., Gudger, A., Ngu, L., Poynton, M., Lam, H. P. J., Morgan, L., Yang, L., Young, J., Walker, M., Tsagkaraki, I., Anderson, L., Chauhan, S. R., Maddams, R., Soutar, R., Triantafillou, M., Prideaux, S., Obeidalla, A., Eyre, T. A., Bygrave, C., Basu, S., & Ramasamy, K. (2022). infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study. Hematology, 27(1), 691–699. http://access.bl.uk/ark:/81055/vdc_100156455615.0x000039